Previous close | 5.0000 |
Open | 5.1000 |
Bid | 3.6000 |
Ask | 5.1000 |
Strike | 80.00 |
Expiry date | 2026-01-16 |
Day's range | 5.0000 - 5.0000 |
Contract range | N/A |
Volume | |
Open interest | 19 |
BD's (BDX) receipt of the FDA's clearance for the use of self-collected vaginal specimens for HPV testing is likely to improve screening access to a wider female population.
Butterfly Network (BFLY) uses proprietary Ultrasound-on-Chip technology to streamline the bladder scanning process.
Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.